RxDoctor Payments Data

Justin McCormick

Otolaryngology · New Brunswick, NJNPI 1508250622

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,218 of the $4,191 with a category attached, or 76.8%. 7 manufacturers reported payments, led by Aerin Medical Inc. at 47.4% of the total. Reporting peaked in 2022 at $1,299 and has fallen 57.5% since, to $552 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,191in general payments, 2019–2025

Across 38 payments — averaging $110.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • GSK$863
  • Acclarent, Inc$479
  • Smith+Nephew$402
  • Medtronic$293
  • Integra Lifesciences Corporation$141
  • plus $24 from 1 others
$104,727in research payments, 2019–2025

Across 37 payments — averaging $2830.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$105K

What the payments were for

  • Consulting fees$80619%
  • Food & beverage$3,21877%
  • Education$1664%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,191 in reported general payments places this provider in the 90th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$56,157
Medicare patients
105
Services billed
392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate107$1,305
Azelastine Hcl68$1,302
Ipratropium Bromide64$1,070
Omeprazole24$572
Doxycycline Monohydrate17$196
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$118
Famotidine12$98
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$93
Prednisone18$31
Oxycodone Hcl16$27

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →